on The Vanguard Group, Inc. (isin : US12572Q1058)
The Vanguard Group Confirms Interest in Life Science REIT plc
The Vanguard Group, Inc. has disclosed its position in Life Science REIT plc through a Form 8.3 submission. The filing, dated 25 February 2026, details Vanguard's interests in securities representing 1% or more. This disclosure is in compliance with Rule 8.3 of the Takeover Code.
The key information reveals Vanguard's ownership of 3,290,584 ordinary shares in Life Science REIT plc, equating to a 0.94% interest. Additionally, Vanguard reported a recent purchase of 8,430 ordinary shares at 0.42 GBP per unit on 24 February 2026.
No agreements, arrangements, or options have been stated by Vanguard in relation to the securities. There are no further attachments or supplemental forms included in the disclosure.
R. P.
Copyright © 2026 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all The Vanguard Group, Inc. news